14. Itescu S, Kocher AA, Schuster MD. Adult bone marrow-derived
angioblasts for improvement of cardiomyocyte function after myocardial
ischemia.
Gene
Ther
Reg.
2001;
1(4):
375-386.
doi:
10.1163/156855801760107037.
15. Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs
autologous bone marrow - derived mesenchymal stem cells delivered by
transendocardial injection in patients with ischemic cardiomyopathy: the
POSEIDON randomized trial. JAMA. 2012; 308(22): 2369.
16. Chin SP, Poey AC, Wong CY, et al. Intramyocardial and intracoronary
autologous bone marrow-derived mesenchymal stromal cell treatment in chronic
severe dilated cardiomyopathy. Cytotherapy. 2011; 13(7): 814-821. doi:
10.3109/14653249.2011.574118.
17. Du YY, Zhou SH, Zhou T, et al. Immuno-inflammatory regulation effect
of mesenchymal stem cell transplantation in a rat model of myocardial infarction.
Cytotherapy. 2008; 10(5): 469-478. doi: 10.1080/14653240802129893.
18. Narita T, Suzuki K. Bone marrow-derived mesenchymal stem cells for
the treatment of heart failure. Heart Fail Rev. 2014; 20(1): 53-68. doi:
10.1007/s10741-014-9435-x.
19. Yannarelli G, Dayan V, Pacienza N, Lee CJ, Medin J, Keating A. human
umbilical cord perivascular cells exhibit enhanced cardiomyocyte reprogramming
and cardiac function after experimental acute myocardial infarction. Cell
Transplant. 2013; 22(9): 1651-1666. doi: 10.3727/096368912X657675. Epub
2012 Oct 4.
20. López Y, Lutjemeier B, Seshareddy K, et al. Wharton’s jelly or bone
marrow Mesenchymal Stromal cells improve cardiac function following
myocardial infarction for more than 32 weeks in a rat model: a preliminary
report. Curr Stem Cell Res Ther. 2013; 8(1): 46-59.
21. Liao W, Xie J, Zhong J, et al. Therapeutic effect of human Umbilical
cord Multipotent Mesenchymal Stromal cells in a rat model of stroke.
Transplantation. 2009; 87(3): 350-359. doi: 10.1097/ TP.0b013e318195742e.
